The 36-month beta value for SNGX is also noteworthy at 1.88. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for SNGX is 3.26M, and at present, short sellers hold a 0.76% of that float. The average trading volume of SNGX on July 01, 2025 was 118.28K shares.
SNGX) stock’s latest price update
The stock price of Soligenix Inc (NASDAQ: SNGX) has jumped by 12.98 compared to previous close of 1.31. Despite this, the company has seen a gain of 11.28% in its stock price over the last five trading days. prnewswire.com reported 2025-07-01 that Active Ingredient Manufacturing Transfer to the U.S. Complete PRINCETON, N.J., July 1, 2025 /PRNewswire/ — Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it has successfully completed the transfer of the manufacturing process for its synthetic hypericin active ingredient under its partnership agreement with Sterling Pharma Solutions (Sterling).
SNGX’s Market Performance
SNGX’s stock has risen by 11.28% in the past week, with a monthly drop of -21.69% and a quarterly drop of -31.16%. The volatility ratio for the week is 7.66% while the volatility levels for the last 30 days are 5.05% for Soligenix Inc The simple moving average for the last 20 days is -12.45% for SNGX’s stock, with a simple moving average of -45.03% for the last 200 days.
Analysts’ Opinion of SNGX
H.C. Wainwright, on the other hand, stated in their research note that they expect to see SNGX reach a price target of $2.70, previously predicting the price at $5.50. The rating they have provided for SNGX stocks is “Neutral” according to the report published on January 31st, 2018.
Maxim Group gave a rating of “Buy” to SNGX, setting the target price at $5 in the report published on August 14th of the previous year.
SNGX Trading at -19.85% from the 50-Day Moving Average
After a stumble in the market that brought SNGX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -90.02% of loss for the given period.
Stock Fundamentals for SNGX
Current profitability levels for the company are sitting at:
- -4541.74 for the present operating margin
- -0.68 for the gross margin
The net margin for Soligenix Inc stands at -2711.89. The total capital return value is set at -1.51. Equity return is now at value -437.73, with -121.33 for asset returns.
Based on Soligenix Inc (SNGX), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at -106.21. The debt to equity ratio resting at 0.02. The interest coverage ratio of the stock is -296.08.
Currently, EBITDA for the company is -8.64 million with net debt to EBITDA at 0.72. When we switch over and look at the enterprise to sales, we see a ratio of -942.47. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.84.
Conclusion
In summary, Soligenix Inc (SNGX) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
